Search Results - "JACOBS, D. C. H"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
  2. 2

    Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia by VERHAGEN, O. J. H. M, WILLEMSE, M. J, BREUNIS, W. B, WIJKHUIJS, A. J. M, JACOBS, D. C. H, JOOSTEN, S. A, VAN WERING, E. R, VAN DONGEN, J. J. M, VAN DER SCHOOT, C. E

    Published in Leukemia (01-08-2000)
    “…Large-scale clinical studies on detection of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) have shown that quantification of MRD levels…”
    Get full text
    Journal Article
  3. 3

    T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis by VAN DER VELDEN, V. H. J, WIJKHUIJS, I. M, JACOBS, D. C. H, VAN WERING, E. R, VAN DONGEN, J. J. M

    Published in Leukemia (01-07-2002)
    “…Several studies have shown that quantitative detection of minimal residual disease (MRD) predicts clinical outcome in childhood acute lymphoblastic leukemia…”
    Get full text
    Journal Article
  4. 4

    Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL by VAN DER VELDEN, V. H. J, JACOBS, D. C. H, WIJKHUIJS, A. J. M, COMANS-BITTER, W. M, WILLEMSE, M. J, HÄHLEN, K, KAMPS, W. A, VAN WERING, E. R, VAN DONGEN, J. J. M

    Published in Leukemia (01-08-2002)
    “…Sensitive and quantitative detection of minimal residual disease (MRD) in bone marrow (BM) samples of children with acute lymphoblastic leukemia (ALL) is…”
    Get full text
    Journal Article
  5. 5